Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca - Related Studies

Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca

This study has been completed.

Study NCT00128245. Last updated on December 19, 2007. Information provided by Novartis

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Keratoconjunctivitis Sicca

2	Additional conditions recognized in this trial
		Keratoconjunctivitis
		Xerophthalmia

3	More general conditions related to this trial
		Conjunctival Diseases
		Conjunctivitis
		Corneal Diseases
		Dry Eye Syndromes
		Eye Diseases
		Keratitis
		Lacrimal Apparatus Diseases

4	Interventions listed in this trial
		Pimecrolimus

5	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Inflammatory Agents
		Anti-Inflammatory Agents, Non-Steroidal
		Antirheumatic Agents
		Central Nervous System Agents
		Dermatologic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Novartis